Abiopharma

New Form 4 - Air Products & Chemicals, Inc. Filed: 2025-07-02 AccNo: 0001225208-25-006282 Size: 5 KB

New Form 4 - Air Products & Chemicals, Inc. Filed: 2025-07-02 AccNo: 0001225208-25-006280 Size: 5 KB

New Form 4 - Air Products & Chemicals, Inc. Filed: 2025-07-02 AccNo: 0001225208-25-006279 Size: 5 KB

New Form 4 - Air Products & Chemicals, Inc. Filed: 2025-07-02 AccNo: 0001225208-25-006281 Size: 5 KB

New Form 6-K - Haleon plc Filed: 2025-07-02 AccNo: 0001654954-25-007670 Size: 107 KB

New Form 6-K - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-07-02 AccNo: 0001395064-25-000111 Size: 687 KB

New Form 4 - Air Products & Chemicals, Inc. Filed: 2025-07-02 AccNo: 0001225208-25-006272 Size: 5 KB

New Form 4 - Air Products & Chemicals, Inc. Filed: 2025-07-02 AccNo: 0001225208-25-006273 Size: 5 KB

New Form 4 - Air Products & Chemicals, Inc. Filed: 2025-07-02 AccNo: 0001225208-25-006275 Size: 5 KB

New Form 4 - Air Products & Chemicals, Inc. Filed: 2025-07-02 AccNo: 0001225208-25-006274 Size: 5 KB

New Form 6-K - Nanobiotix S.A. Filed: 2025-07-02 AccNo: 0001628280-25-033844 Size: 1 MB

Qiagen N.V. - QIAGEN announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2027

Qiagen N.V. - QIAGEN announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2031

New Form SCHEDULE 13G - Inmune Bio, Inc. Filed: 2025-07-02 AccNo: 0001649553-25-000121 Size: 15 KB

Auxly Announces Results of Annual General Meeting of Shareholders